This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): RN1219
Description: RN1219 is a monoclonal antibody that binds to amyloid beta in the plasma and effectively removes it from the brain. Amyloid beta is the putatative cause of Alzheimer's disease.
Deal Structure: RN1219 was discovered by Rinat. In 2006, Pfizer acquired Rinat.
Pink Sheet FDA Recalls – Aug. 17, 2011
Additional information available to subscribers only: